The E6 oncoprotein of human papillomaviruses (HPVs) has the potential to functionally antagonize p53. In several experimental model systems, ectopic expression of E6 can block the genotoxic induction of the growth inhibitory p53 target gene gadd45, suggesting that the inactivation of this pathway may play a major role for HPV-associated cell transformation. Here, we investigated whether this re¯ects the regulation of gadd45 expression in carcinoma-derived HPV-positive cells. We found that the gadd45 gene is eciently induced by mitomycin C, cisplatin, and UV irradiation in a series of HPV-positive cervical cancer cell lines. Moreover, clear induction of gadd45 gene expression was also observed following treatment with g-irradiation, a pathway that is strictly dependent on functional p53. This contrasted with ®ndings in human foreskin keratinocytes experimentally immortalized by expressing the HPV16 E6, E7, or E6/E7 oncogenes from the heterologous CMV promoter, where expression of the E6 gene was linked to a lack of gadd45 induction following g-irradiation.
Introduction
Human papillomaviruses (HPVs) are causally involved in the development of cervical carcinomas, representing the second most common cancer form in women worldwide (zur Hausen, 1996) . The oncogenic potential of tumor-associated (so called`high risk') HPV types maps to the viral E6 and E7 genes whose gene products form complexes with the cellular tumor suppressor proteins p53 and pRb, respectively. The E6 oncoprotein has been shown to induce the degradation of p53 and to inhibit the activity of p53 as a transcription factor (reviewed in Hoppe-Seyler and Schener, 1997) . Moreover, ectopic expression of high risk E6 protein in various cell types blocked p53-associated cellular responses to DNA damage, such as activation of the p53 target gene p21 WAF1 , cell cycle arrest in G1, or induction of apoptosis (Kessis et al., 1993; Foster et al., 1994; Liu et al., 1997) .
While these observations indicate that ectopic expression of the E6 oncogene can lead to the same functional consequences as p53 mutations, analyses of p53-associated pathways in HPV-positive cell lines derived from cervical cancers indicate that this may be an oversimpli®ed view. In these cells, the viral E6 and E7 genes are integrated into the chromosomal DNA and are expressed from the authentic HPV E6/ E7 promoter. In contrast to the experimental cell systems mentioned above, several cervical carcinoma cell lines have been shown to react to genotoxic treatment by inducing the p53 target gene p21 WAF1 , G1 arrest and/or induction of apoptosis (Butz et al., 1995 (Butz et al., , 1996 . This could be explained by the very low levels of E6 protein expression in carcinoma derived tumor cells which may limit p53 inhibition. On the other hand, it also is possible that p53-independent pathways contribute to the ability of HPV-positive cancer cells to induce cell cycle arrest or apoptosis following DNA damage. For example, the growth inhibitory p21 WAF1 gene can also be activated by genotoxic agents via p53-independent pathways (Johnson et al., 1994; Loignon et al., 1997; Butz et al., 1998) . Thus, although HPV-positive cancer cells can exhibit at least some features of an intact cellular response to genotoxic stress, the underlying mechanisms are still unresolved and it is not yet clear whether HPV-positive cancer cells contain enough functional p53 to transactivate a physiological target gene following DNA damage.
The gadd (growth arrest and DNA damage) 45 gene is a downstream target for p53 and is transcriptionally activated by wildtype (wt) p53 protein during the cellular response to DNA damage . Its gene product exhibits growth inhibiting potential and can induce cell cycle arrest in G1 Zhan et al., 1994b) . This may be related to the ability of GADD45 to directly bind the p21 WAF1 and the PCNA (proliferating cell nuclear antigen) proteins Kearsey et al., 1995a) . In addition, GADD45 has been reported to stimulate nucleotide excision repair , although this has been disputed by other researchers (Kearsey et al., 1995b) . By inducing cell cycle arrest in G1, which presumably allows repair of acquired genetic lesions before entry into S phase, and possibly by a direct contribution to DNA repair, the gadd45 gene may be an important mediator of the antioncogenic activity of p53 following DNA damage.
A series of investigations have shown that the induction of gadd45 expression following g-irradiation is strictly dependent on wtp53 function and is not observed in cells in which the p53 gene is functionally inactivated by mutation (Kastan et al., 1992; Zhan et al., 1994a; O'Connor et al., 1997) . Thus, the analysis of gadd45 expression following g-irradiation provides a useful tool to investigate whether the endogenous p53 within a given cell is functional. Other genotoxic agents, such as alkylating agents or UV irradiation, can induce gadd45 expression to some degree independently of p53. However, also for these agents, p53 signi®cantly contributes to gadd45 activation, since the level of induction is typically much greater in cells with wtp53 than in cells with mtp53, and ectopic expression of p53-antagonists strongly reduced gadd45 induction by these agents (Zhan et al., 1996) .
Recent studies have indicated that the induction of gadd45 mRNA by genotoxic stress is greatly diminished or completely abolished in human oral keratinocytes that have been experimentally immortalized with HPV16-or HPV18 DNA (Gujuluva et al., 1994; Shin et al., 1996) . Moreover, oral keratinocytes ectopically expressing the viral E6 oncogene from a retroviral vector exhibited a complete loss of gadd45 induction (Liu et al., 1997) . This suggested that E6-mediated inhibition of gadd45 induction may play a crucial role for HPV-associated carcinogenesis. In the present study, we investigated whether these experimental settings re¯ect the regulation of gadd45 expression in tumor-derived HPV-positive cancer cells and whether their tumorigenic phenotype is indeed linked to an inability to induce gadd45 in response to DNA damage. We also aimed at obtaining direct evidence whether the endogenous p53 protein in HPV-positive cervical cancer cells is functionally competent to activate a downstream target gene.
Results
To investigate the gadd45 response in HPV-positive cancer cells, a series of cervical carcinoma cell lines which contain both high risk E6 sequences and wtp53 genes (Schener et al., 1991) , were treated with the alkylating agent mitomycin C (mitC). Subsequently, gadd45 expression was compared between treated cells and untreated controls. With the exception of HPV18-positive HeLa cells, all HPV-positive cervical carcinoma cell lines, namely HPV18-positive C4-I, C4-II, SW756, HPV68-positive Me180, and HPV16-positive SiHa and CaSKi cells showed a clear induction of gadd45 mRNA levels following mitC treatment ( Figure  1) . Similarly, HPV-negative control cells, such as primary keratinocytes and HepG2 hepatoma cells, containing transcriptionally active wtp53 (HoppeSeyler and Butz, 1993) , exhibited an induction of gadd45 following mitC treatment. This was also observed for wtp53 containing MCF-7 breast cancer cells, which served as a further positive control since they have been previously shown to induce gadd45 after genotoxic stress (Zhan et al., 1996) . In addition, gadd45 was upregulated in Osa-CL cells, an osteosarcoma cell line overexpressing the potential p53 antagonist mdm-2 . The gadd45 response in HPV-positive cell lines and in HPVnegative control cells containing wildtype p53 strongly diered from that in cell lines containing p53 gene defects (Schener et al., 1991; Mitsudomi et al., 1992) : in the HPV-negative HT3 cervical carcinoma cell line, gadd45 was induced to only very low levels and both HPV-negative C33 cervical cancer cells and H1299 lung cancer cells did not show any induction at all. Thus, various HPV-positive cancer cell lines are clearly able to induce gadd45 expression following genotoxic stress with an eciency that is comparable to primary keratinocytes or to HPV-negative cell lines containing transcriptionally active p53.
To gain further insight into the regulation of gadd45 expression in HPV-positive cancer cells, we performed kinetic analyses in HPV16-positive CaSKi and in HPV18-positive C4-II and SW756 cells. As shown in Figure 2 , gadd45 induction was already detectable at 2 ± 4 h following exposure to the DNA damaging agent in all three cell lines, and, within the time period investigated, maximal induction was observed after 10 ± 14 h in CaSKi and SW756 cells and after 24 h in C4-II cells. Thus, gadd45 expression is induced rapidly in HPV-positive cancer cells following mitC treatment which is in line with the rapid induction of gadd45 expression in cells with intact p53 by other DNA damaging agents, including another alkylating agent, methylmethane sulfonate (Jackman et al., 1994; Kearsey et al., 1995a) .
Next, we investigated whether induction of gadd45 expression is also observed following exposure to other genotoxic agents, causing dierent types of DNA lesions. As shown in Figure 3 , gadd45 expression was also clearly induced in the HPV-positive cancer cell lines C4-II, SW756, SiHa, and CaSKi following treatment with the crosslinking agent cisplatin. Similarly, UV irradiation, which typically results in pyrimidine dimers and the 6-4 photoproduct (Whitaker, 1992) , also clearly induced gadd45 expression in these cells. Thus, the ability of HPV-positive cancer cells to induce gadd45 after genotoxic stress is not limited to DNA lesions caused by the methylating agent mitC, but can also be observed with other genotoxic agents associated with dierent types of DNA damage.
Kinetic studies were performed to analyse the p53-dependent gadd45 response to g-irradiation. As shown in Figure 4a , gadd45 expression was clearly inducible by this agent in HPV-positive C4-II, SW756, SiHa, and CaSKi carcinoma cells. As observed for the response of gadd45 to g-irradiation in other cell types (Zhan et al., 1994a) , induction was rapid and detectable after 3 h in the HPV-positive cancer cells. After 24 h, gadd45 mRNA levels returned to almost basal levels in C4-II and SiHa cells while they remained elevated in SW756 and CaSKi cell. Quanti®cation of mRNA levels, normalized to GAPDH expression, indicates maximal increases of gadd45 expression in the range of 3.8-fold (C4-II, at 3 h after g-irradiation), 4.8-fold (SW756, at 6 h), 3.4-fold (SiHa, at 3 h) and 3.6-fold (CaSKi, at 12 h), when compared with untreated controls. Treatment of primary keratinocytes also resulted in a rapid increase of gadd45 expression within approximately the same quantitative range as observed for the HPV-positive cancer cell lines (3.1-fold at 3 h). In contrast, p53-mutant HT3 exhibited only a very marginal induction, if at all, following g-irradiation (maximal induction 1.5-fold after 6 h), and, for as yet unknown reasons, even showed a substantial reduction of gadd45 mRNA levels at later time points. Similarly, no appreciable gadd45 induction was observed in p53 null H1299 cells (data not shown). As depicted in Figure 4b , gadd45 mRNA induction following girradiation did not necessarily correlate with changes in total p53 protein levels, e.g. strong gadd45 induction was detected in CaSKi at 6 h (Figure 4a ) which precedes the increase of p53 protein levels at 12 h (Figure 4b ), while p53 protein levels were largely unaltered in C4-II, SW756, SiHa and primary human foreskin keratinocytes despite upregulation of gadd45 expression.
These results show that, in contrast to previous reports investigating the in¯uence of high risk E6 on gadd45 expression in experimental cell systems (Gujuluva et al., 1994; Shin et al., 1996; Zhan et al., 1996; Liu et al., 1997) , gadd45 can be clearly induced in tumor-derived HPV-positive cancer cells by several genotoxic agents. We therefore compared the regulation of gadd45 expression in human foreskin keratinocytes immortalized by retroviral vectors expressing the HPV16 E6, HPV16 E7, or HPV16 E6/E7 genes, respectively, from the CMV promoter (Whitaker and zur Hausen, manuscript in preparation). Gadd45 expression was clearly inducible in all three types of immortalized keratinocytes by mitC and cisplatin treatment (Figure 5a ). In contrast, as shown in Figure  5b , g-irradiation only very marginally, if at all, induced gadd45 in E6 and E6/E7 expressing cell lines, but led to a signi®cant induction in the E7 expressing cells (3.0-fold at 6 h following irradiation). Under these conditions, g-irradiation had no eect on viral E6, E7, or E6/E7 expression (Figure 5b ). These results show that, in contrast to HPV-positive cervical cancer cells, human foreskin keratinocytes expressing the HPV16 E6 or E6/E7 genes from the CMV promoter are severely impaired in their ability to induce the p53-dependent gadd45 pathway following g-irradiation. Moreover, in this experimental cell system, lack of gadd45 induction following g-irradiation, but not following treatment with mitC or cisplatin, was linked to the expression of the HPV16 E6 oncogene.
Discussion
In this study we show that gadd45 gene expression can be strongly stimulated in cervical cancer cells by the alkylating agent mitomycin C, the cross-linking agent cisplatin, and by UV irradiation, despite that these cells contain high risk HPV sequences. Moreover, girradiation also clearly stimulated gadd45 gene expression, a pathway that is shown to be strictly dependent on the presence of functional p53. Thus, the tumorigenic phenotype of HPV-positive cancer cells does not correlate with an inability to induce the gadd45 gene following DNA damage. Moreover, the p53 levels contained in tumor derived HPV-positive cell lines are sucient to eciently stimulate the activity of a downstream p53 target gene after genotoxic stress. These ®ndings are in contrast with several studies expressing the HPV E6 oncogene in other cell types and/or from heterologous promoters. For example, human oral keratinocytes, immortalized by stably expressing the HPV16 or HPV18 E6/E7 genes from cloned viral genomes, showed severe defects in the gadd45 response and exhibited a greatly reduced induction, or no induction at all, of gadd45 mRNA levels after DNA damage (Gujulova et al., 1994; Shin et al., 1996; Liu et al., 1997) . Expression of HPV16 E6 from the heterologous CMV promoter in the p53 wildtype cell lines MCF-7 and RKO completely abolished gadd45 induction following g-irradiation (Zhan et al., 1996) . Moreover, ectopic expression of HPV16 E6 after infection with retroviral vectors completely abolished gadd45 induction in oral keratinocytes following genotoxic stress (Liu et al., 1997) . These results implied that, in the process of viral carcinogenesis, HPVs follow the strategy to inactivate the gadd45 pathway via E6-mediated inhibition of p53. The present investigation contradicts this view and, on the contrary, indicates that the gadd45 gene is clearly inducible by various types of genotoxic stress in cancerderived cell lines despite containing oncogenic HPV types. As a matter of fact, among the series of HPVpositive cancer cell lines investigated in this study, only HeLa cells exhibited a lack of gadd45 inducibility. It furthermore is noteworthy that many HPV-positive cancer cell lines can induce both the gadd45 gene (this study) and G1-arrest in response to DNA damage (Butz et al., 1995) . However, these two parameters do not strictly correlate, since, for example, SiHa cells are severely impaired in their ability to induce a G1 arrest following mitC or cisplatin treatment (Butz et al., 1995 and data not shown) but yet showed a clear induction of gadd45 following treatment with these agents.
Dierent scenarios could be envisioned to explain the dierences in gadd45 regulation between the model systems mentioned above and the cancer-derived cell lines investigated in the present study. E6 protein levels are presumably very low in HPV-positive carcinoma cell lines and therefore may be limited in their inhibition of p53. In contrast, ectopic expression of E6 from heterologous promoters in experimental cell systems may result in higher E6 levels and more ecient inhibition of p53 and p53-associated pathways than in HPV-positive cancers. In addition, there may also be cell speci®c dierences in the regulation of gadd45 between MCF-7 breast cancer, RKO colon cancer and oral keratinocytes on the one hand and HPV-positive cancer cell lines derived from the cervix uteri on the other hand. In line with these possibilities, we also found that immortalized human foreskin keratinocytes expressing the HPV16 E6 gene alone, or the HPV16 E6 and E7 genes in combination, from the heterologous CMV promoter were severely impaired in their ability to induce gadd45 following g-irradiation. In contrast, when these cells expressed only the HPV16 E7 gene, the gadd45 gene was induced. Thus, as similarly observed for other experimental systems (Zhan et al., 1996; Liu et al., 1997) , impairment of gadd45 induction following girradiation was linked to expression of the HPV16 E6 gene, but this strongly diered from the gadd45 response in HPV-positive cancer cell lines.
Another important p53 target gene, namely the p21 WAF1 gene, is also induced by DNA-damage in cervical cancer cells (Butz et al., 1995 (Butz et al., , 1998 . However, since p21 WAF1 can be induced also via p53-independent pathways following genotoxic stress, it was not possible to dierentiate from these results whether the cells contain enough p53 to transcriptionally activate this cellular target gene or whether p21 WAF1 induction occurred independently of p53. The ecient induction of gadd45 by g-irradiation provides direct evidence for the notion that the endogenous p53 protein in HPV- , 1997) . Interestingly, while gadd45 induction by g-irradiation is strictly dependent on functional p53 (Kastan et al., 1992; Zhan et al., 1994a; O'Connor et al., 1997) , we did not observe a correlation between p53 protein levels and gadd45 expression. This is in line with the ®nding that the transcriptional activity of p53 in keratinocytes (Weinberg et al., 1995) , and in other cell types (Lu et al., 1996) , does not necessarily correlate with the p53 protein content, possibly because of a cellular pool of latent p53 that can be activated through posttranslational modi®cations (e.g. Hupp et al., 1992; Gu and Roeder, 1997; Jayaraman et al., 1997) . In addition, while genotoxic agents other than g-irradiation, such as alkylating agents, can induce gadd45 also partly independently of p53, the level of induction is frequently greater in cells containing functional p53 (Zhan et al., 1996) . In concordance with the notion that the p53 protein is functional in HPV-positive cell lines, we observed a much higher level of gadd45 induction in these cells following exposure to the alkylating agent mitC than in cell lines containing p53 gene defects. Notably, while certain genotoxic agents, such as mitC, cisplatin, or UV irradiation can downmodulate viral E6/E7 gene expression in HPV-positive cancer cells, no eect on E6/E7 expression is observed by g-irradiation under the experimental conditions employed in this study (Butz et al., 1998) . This indicates that a reduction of E6/E7 expression is not a prerequisite for ecient gadd45 stimulation, but rather that the endogenous p53 pool in these cells is sucient to mediate the activation of this target gene. This study supports the notion that p53-dependent response pathways to DNA damage are principally inducible in HPV-positive cancer cells. This clearly diers from the situation in cells containing p53 gene defects, indicating that the presence of high risk HPV DNA in a tumor cell does not result in the same phenotype as a somatic mutation of the p53 gene.
Rather, the level of high risk E6 in HPV-positive cancer cells appears to be limited in its ability to inactivate p53 and p53-associated pathways. It should, however, be noted that our study does not dispute a signi®cant role for the E6 protein during HPVassociated carcinogenesis. For example, it is still possible that the low levels of E6 expression in these cells can lead to very subtle increases in genetic instability which over a long time period may ultimately result in the accumulation of critical gene defects. Indeed, HPV-positive carcinomas are characterized by a long latency period between initial infection and cancer development, typically in the range of decades. On the other hand, and not mutually exclusive, the crucial role for E6 in HPV-associated carcinogenesis, particularly for the maintenance of the malignant phenotype, could be related to its ability to inhibit apoptosis. In this scenario, E6 counteracts the apoptotic elimination of cells under the growth deregulatory in¯uence of the viral E7 gene Griep, 1994, 1995) .
Materials and methods

Cell culture and genotoxic treatment
All cells were grown in Dulbecco's minimal essential medium (pH 7.2), supplemented with fetal calf serum, with the exception of primary and E6-, E6/E7-, and E7-immortalized human foreskin keratinocytes which were cultured in keratinocyte growth medium (Promocell, Heidelberg, Germany). For genotoxic treatment, exponentially growing cells were exposed to either 10 mg/ml mitomycin C (Sigma, Deisenhofen, Germany), 10 mg/ml cisplatin (ASTA Medica, Frankfurt, Germany), 50 J/m 2 UV-irradiation (UV Stratalinker 2400, Stratagene, Heidelberg, Germany), or 20 gy g-irradiation employing a 137 Cs source (Gammacell 1000, Atomic Energy of Canada Ltd., Canada), respectively. Unless otherwise indicated in the ®gures, cells were harvested 24 h following treatment for further analysis.
Northern-and Western Blot analyses
RNA was prepared by guanidinium-isothiocyanate-phenol chloroform extraction (Chomczynski and Sacchi, 1987 Approximately 5 mg of RNA were separated on an 1% agarose gel, transferred to a Hybond-N + -nylon membrane (Amersham, Brauschweig, Germany) and analysed by Northern blotting using a 269 bp fragment of the gadd45 cDNA (SmaI/EcoRI fragment of pRibo-Hg45 [Kastan et al., 1992] ) or a 1.3 kb EcoRI/PstI fragment of the HPV16 E6/E7 region (Butz et al., 1998) as 32 P-radiolabeled hybridization probes. To monitor integrity of the RNA and to account for loading variations between individual lanes, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was used as an internal control probe. RNA levels were quantitated by densitometric scanning using an HP Scan Jet IIC scanner (Hewlett Packard) and ImageQuant TM version 3.3 software (Molecular Dynamics, Krefeld, Germany). After normalizing to GAPDH expression, the levels of gadd45 induction were determined relative to untreated control cells.
For Western blot analyses, protein was extracted from the cells in RIPA buer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP40, 0.5% sodium deoxycholate and 0.1% SDS). Approximately 20 mg of protein was separated by 10% SDS ± PAGE, transferred to a Immobilon-P membrane (Millipore, Bedford, USA) and analysed by enhanced chemiluminescence (ECL kit, Amersham, Braunschweig, Germany) using the anti-p53 antibody DO-1 (Pharmingen, San Diego, USA). To allow a direct comparison of gadd45 mRNA and p53 protein levels, RNA and protein were prepared for each cell line from duplicate tissue culture dishes, treated identically in the same experimental setting.
